Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IM Cannabis (IMCC) Other Accumulated Expenses (2019 - 2025)

Historic Other Accumulated Expenses for IM Cannabis (IMCC) over the last 3 years, with Q3 2025 value amounting to $10.1 million.

  • IM Cannabis' Other Accumulated Expenses changed N/A to $10.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.1 million, marking a year-over-year change of. This contributed to the annual value of $3.7 million for FY2024, which is 2074.06% down from last year.
  • IM Cannabis' Other Accumulated Expenses amounted to $10.1 million in Q3 2025.
  • Over the past 5 years, IM Cannabis' Other Accumulated Expenses peaked at $10.1 million during Q3 2025, and registered a low of $3.6 million during Q4 2024.
  • For the 3-year period, IM Cannabis' Other Accumulated Expenses averaged around $6.0 million, with its median value being $5.8 million (2025).
  • The largest annual percentage gain for IM Cannabis' Other Accumulated Expenses in the last 5 years was 2161.83% (2024), contrasted with its biggest fall of 2161.83% (2024).
  • Over the past 3 years, IM Cannabis' Other Accumulated Expenses (Quarter) stood at $4.6 million in 2023, then dropped by 21.62% to $3.6 million in 2024, then skyrocketed by 182.41% to $10.1 million in 2025.
  • Its Other Accumulated Expenses was $10.1 million in Q3 2025, compared to $5.8 million in Q2 2025 and $6.0 million in Q1 2025.